Site icon InvestyWise

Lupin SBTi Validates Emission Reduction Targets

Global pharma major Lupin Limited announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). These targets cover all three emission scopes – Scope 1, Scope 2, and Scope 3 – aligning with the Paris Agreement to limit global temperature rise to 1.5°C. This validation underscores Lupin’s commitment to sustainability and decisive climate action.

Lupin’s Commitment to Climate Action

Lupin Limited (Lupin) announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). This validation positions Lupin among a select group that has achieved comprehensive SBTi validation within a year of setting its climate targets.

Key Emission Reduction Targets

The company is focusing on achieving significant reductions in greenhouse gas emissions with the following targets:

These goals are aligned with the 1.5°C pathway and validated under SBTi’s latest guidelines, thereby positioning Lupin as a key participant in the global effort to combat climate change.

Leadership Perspective

Ramesh Swaminathan, Executive Director, Global CFO, and Head of IT and API Plus SBU, Lupin, stated, “The validation from SBTi underscores Lupin’s unwavering commitment to reducing greenhouse gas emissions through a rigorous, science-driven approach. By setting ambitious targets, we are embedding sustainability into both our financial and operational strategies. These goals guide investments in renewable energy, energy efficiency, and low-carbon technologies across our global operations. Proactive action on climate change is essential not only for mitigating risks and optimising costs but also for unlocking opportunities for innovation and long-term growth.”

Source: BSE

Exit mobile version